Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Authors
Taha Merghoub (ORCID: https://orcid.org/0000-0002-1518-5111)
Xuejun Chen
Dana B. Cardin (ORCID: https://orcid.org/0000-0002-0269-9615)
Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar et al.
Topics
Neuroblastoma Research and Treatments
article
Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar, Omid Hamid, Patricia LoRusso, James J. Harding, Roberta Zappasodi, Zhiwan Dong, F. Stephen Hodi, Feng Zhou, Manfred Velden, John E. Janik
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors — Taha Merghoub, Xuejun Chen, et al. · (2025) | TGRS Research Map | TGRS